COLLABORATING MEDICAL CENTERS

Gorman Cardiovascular Research Group

UT Southwestern Radiology

Wafic Said Molecular Cardiology Lab

Austin Heart Hospital

UT Dell Medical School
COLLABORATING ENGINEERING LABORATORIES

Cardiovascular Fluid Mechanics Laboratory

Artificial Heart & Cardiovascular Fluid Dynamics Lab

Computational Fluid-Structure Interaction Laboratory

LATEST NEWS:
Research Scientist Joao Soares Wins Best Poster Award at FIMH Conference
CCS research scientist Joao Soares won the Best Poster award at the FIMH Conference this year in Toronto, for his research on in-silico CCS heart modeling.
FIMH 2017 is the 9th international conference on Functional Imaging and Modeling of the Heart. This biennial scientific event aims to integrate the state of the art research and novel development efforts in the fields of cardiovascular imaging, image analysis and heart modelling. The main goal is to encourage collaboration among students, junior and senior scientists working in signal and image processing, imaging, applied mathematics, biophysics, biomedical engineering, and experts in cardiology, radiology, biology and physiology.

Details of the FIMH are at the event's website.


MISSION STATEMENT:
The overarching goal of the Center for Cardiovascular Simulation (CCS) is developing computational biomechanical models for understanding heart valve and heart disease progression for developing clinical interventions, including prosthetics devices. We develop or utilize a range of unique in-vivo and in-vitro data for elucidating mechanisms that underlie the observed pathologies.  Our modeling focus is the detailed incorporation of this data to provide a high level of physical and physiological realism and validation, working at the continuum-cellular, fibrous tissue, and whole organ levels. We ultimately seek to provide cardiovascular scientists and clinicians with advanced simulations for the rational development of treatments for structural heart and heart valve diseases. Such simulations can ultimately lead to reduction in development time, lowering of morbidity and mortality, reduced re-operative rates, and lessened post-operative recovery time. Moreover, the development and use of these tools in the context of patient-specific models will ultimately also allow clinicians to craft cardiovascular therapies that are optimized for the cardiovascular system of individuals, with a resulting increase in success and decrease in risk adverse side effects.

Michael Sacks, Director


CCS Group photo taken June 11, 2015

Downloadable Brochure (PDF)